• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

儿童慢性充血性心力衰竭的管理

Management of Chronic Congestive Heart Failure in Children.

作者信息

Balfour Ian

机构信息

Department of Pediatrics, Saint Louis University School of Medicine, 1465 S. Grand Boulevard, St. Louis, MO 63104, USA.

出版信息

Curr Treat Options Cardiovasc Med. 2004 Oct;6(5):407-416. doi: 10.1007/s11936-004-0024-5.

DOI:10.1007/s11936-004-0024-5
PMID:15324616
Abstract

The medical management of congestive heart failure involves manipulating myocardial contractility and loading conditions to achieve optimal performance. Medication may be used to counteract potentially deleterious neurohumoral changes that are associated with congestive heart failure. When appropriate, the correction of the underlying cardiac defect by surgery or catheter intervention is usually the most effective treatment for congestive heart failure in children.

摘要

充血性心力衰竭的药物治疗包括调节心肌收缩力和负荷条件，以实现最佳性能。药物可用于对抗与充血性心力衰竭相关的潜在有害神经体液变化。在适当的时候，通过手术或导管介入纠正潜在的心脏缺陷通常是治疗儿童充血性心力衰竭最有效的方法。

相似文献

1
Management of Chronic Congestive Heart Failure in Children.儿童慢性充血性心力衰竭的管理
Curr Treat Options Cardiovasc Med. 2004 Oct;6(5):407-416. doi: 10.1007/s11936-004-0024-5.
2
Apparent paradox of neurohumoral axis inhibition after body fluid volume depletion in patients with chronic congestive heart failure and water retention.慢性充血性心力衰竭伴水潴留患者体液量减少后神经体液轴抑制的明显矛盾现象。
Br Heart J. 1994 Dec;72(6):534-9. doi: 10.1136/hrt.72.6.534.
3
Pathophysiology of congestive heart failure.充血性心力衰竭的病理生理学
Am J Cardiol. 1985 Jan 11;55(2):9A-14A. doi: 10.1016/0002-9149(85)90790-8.
4
Should beta-blockers be used for the treatment of pediatric patients with chronic heart failure?β受体阻滞剂是否应用于治疗小儿慢性心力衰竭患者？
Paediatr Drugs. 2002;4(12):771-8. doi: 10.2165/00128072-200204120-00001.
5
[Congenital heart disease and acquired valvular lesions in pregnancy].[妊娠期先天性心脏病与获得性瓣膜病变]
Herz. 2003 May;28(3):227-39. doi: 10.1007/s00059-003-2467-y.
6
Short-term effects of naloxone on hemodynamics and baroreflex function in conscious dogs with pacing-induced congestive heart failure.纳洛酮对起搏诱导的充血性心力衰竭清醒犬血流动力学和压力反射功能的短期影响。
J Am Coll Cardiol. 1994 Jan;23(1):194-200. doi: 10.1016/0735-1097(94)90520-7.
7
Congestive heart failure--pathophysiology and medical treatment.充血性心力衰竭——病理生理学与药物治疗
J Cardiovasc Pharmacol. 1986;8 Suppl 1:S36-52.
8
Neurohumoral Mechanisms in Congestive Heart Failure and the Role of Drugs with Multiple Actions: A Review of Carvedilol.
Am J Ther. 1996 Mar;3(3):237-247. doi: 10.1097/00045391-199603000-00010.
9
Pharmacology of carvedilol: rationale for use in hypertension, coronary artery disease, and congestive heart failure.卡维地洛的药理学：用于高血压、冠状动脉疾病和充血性心力衰竭的理论依据。
Cardiovasc Drugs Ther. 1997 May;11 Suppl 1:247-56. doi: 10.1023/a:1007735729121.
10
The role of anemia in congestive heart failure and chronic kidney insufficiency: the cardio renal anemia syndrome.贫血在充血性心力衰竭和慢性肾功能不全中的作用：心肾贫血综合征。
Perspect Biol Med. 2004 Autumn;47(4):575-89. doi: 10.1353/pbm.2004.0072.

本文引用的文献

1
The Registry of the International Society for Heart and Lung Transplantation: Sixth Official Pediatric Report--2003.国际心肺移植学会登记处：2003年第六份官方儿科报告
J Heart Lung Transplant. 2003 Jun;22(6):636-52. doi: 10.1016/s1053-2498(03)00184-0.
2
B-type natriuretic peptides: a diagnostic breakthrough for clinicians.B型利钠肽：临床医生的诊断突破
Rev Cardiovasc Med. 2003 Spring;4(2):72-80.
3
A guide to device selection: cardiac resynchronization therapy alone or in combination with an implantable cardioverter defibrillator.
设备选择指南：单独使用心脏再同步治疗或与植入式心律转复除颤器联合使用
Rev Cardiovasc Med. 2003;4 Suppl 2:S47-54.
4
Management of advanced heart failure.晚期心力衰竭的管理
Clin Cornerstone. 2002;4(6):42-52. doi: 10.1016/s1098-3597(02)90035-9.
5
Pharmacologic therapy for patients with chronic heart failure and reduced systolic function: review of trials and practical considerations.慢性心力衰竭且收缩功能降低患者的药物治疗：试验综述与实际考量
Am J Cardiol. 2003 May 8;91(9A):18F-40F. doi: 10.1016/s0002-9149(02)03336-2.
6
Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction.自体骨骼肌成肌细胞移植治疗严重心肌梗死后左心室功能障碍。
J Am Coll Cardiol. 2003 Apr 2;41(7):1078-83. doi: 10.1016/s0735-1097(03)00092-5.
7
Which patient, which pump?
J Heart Lung Transplant. 2003 Mar;22(3):221-35. doi: 10.1016/s1053-2498(02)00468-0.
8
Nesiritide: a unique therapeutic cardiac peptide.奈西立肽：一种独特的治疗性心脏肽。
Rev Cardiovasc Med. 2001;2 Suppl 2:S25-31.
9
Cardiac resynchronization in chronic heart failure.慢性心力衰竭中的心脏再同步化
N Engl J Med. 2002 Jun 13;346(24):1845-53. doi: 10.1056/NEJMoa013168.
10
Carvedilol as therapy in pediatric heart failure: an initial multicenter experience.卡维地洛用于小儿心力衰竭治疗：初步多中心经验
J Pediatr. 2001 Apr;138(4):505-11. doi: 10.1067/mpd.2001.113045.